Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 

       2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

activa pharma Taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Buprenorphine HCl Manufacturers in India Suppliers Buprenorphine HCl Exporters Distributors Buprenorphine HCl api active pharmaceuticals ingredients Buprenorphine HCl manufacturers Side Effects bulk drugs raw material Buprenorphine HCl companies Side Effects Importers Buprenorphine HCl Buprenorphine HCl Exporters Buprenorphine HCl exporters FDA Buprenorphine HCl DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Buprenorphine Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Buprenorphine Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Buprenorphine Hydrochloride active pharmaceutical ingredients Buprenorphine Hydrochloride committee active pharmaceutical ingredients manufacturer Buprenorphine Hydrochloride Active Pharmaceutical Ingredients manufacturer Buprenorphine Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Buprenorphine HCl, Buprenorphine HCl manufacturer India, Buprenorphine HCl product, Buprenorphine HCl products, Api preparation, Certificate of Analysis API manufacturer product, Buprenorphine HCl anti ulcer product, Certificate of Origin COA Buprenorphine HCl COS Buprenorphine HCl, pharmaceutical generic, pharmaceutical drug, medical, Buprenorphine HCl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Buprenorphine HCl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Buprenorphine HCl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Buprenorphine HCl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Buprenorphine HCl ingredients, api, HIV Buprenorphine HCl, tablets, capsules, syrup & protein Buprenorphine HCl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Buprenorphine HCl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Buprenorphine HCl WHO, UKMHRA Approval

   API >>>
   Pharmaceuticals API List
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us

 research lab





HOME >> API >> API List 4 >> Buprenorphine HCl >> Drug Description

Buprenorphine HCl  CAS No: [53152-21-9]

Buprenorphine HCl CAS No: [53152-21-9]

Buprenorphine hydrochloride is a white powder, weakly acidic with limited solubility in water (17 mg/mL). Chemically, buprenorphine is 17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-6,14-ethenomorphinan-7-methanol, hydrochloride [5α,7α(S|]-. Buprenorphine hydrochloride has the molecular formula C29H41NO4 HCI and the molecular weight is 504.10.

A thebaine derivative, buprenorphine is a synthetic partial opiate agonist. It occurs as a white, crystalline powder with a solubility of 17 mg/ml in water and 42 mg/ml in alcohol. The commercially available injectable product  has a pH of 3.5-5 and is a sterile solution of the drug dissolved in D5W. Terms of potency are expressed in terms of buprenorphine. The commercial product contains 0.324 mg/ml of buprenorphine HCl, which is equivalent to 0.3 mg/ml of buprenorphine.

Buprenorphine has partial agonist activity at the mu receptor. This is in contrast to pentazocine which acts as an antagonist at the mu receptor. Buprenorphine is considered to be 30 times as potent as morphine and exhibits many of the same actions as the opiate agonists; it produces a dose-related analgesia. It appears to have a high affinity for mu receptors in the CNS, which may explain its relatively long duration of action.

The cardiovascular effects of buprenorphine may cause a decrease in both blood pressure and cardiac rate. Rarely, human patients may exhibit increases in blood pressure and cardiac rate. Respiratory depression is a possibility, and decreased respiratory rates have been noted in horses treated with buprenorphine. Gastrointestinal effects appear to be minimal with buprenorphine

Information Associated with Product:
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Buprenorphine HCl

Api Manufacturer,Export,Supplies,Manufacturing in India



Buprenorphine HCl

Dihydrocodeine hydrogentartrate

Ethylmorphine HCl


Hydroxychloroquine sulphate


Noscapine base



Phenobarbital acid

Phenobarbital sodium


Copyright Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

      Investor Relations    Feedback     Contact Worldwide    Sitemap

taj group logo
2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.